Companies
Institute of Microbiology, CAS
metabolic engineering of microalgae with more efficient carbon-fixing enzymes (RuBisCO) for faster photosynthesis at low atmospheric CO2.
- Country
- China
Coverage
| CN | EU | US | |
|---|---|---|---|
| cdr-carbon-management | ✓ | ✓ | ✓ |
Regulatorsepa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Affiliation | Chinese Academy of Sciences (CAS) | english.im.cas.cn |
| Research focus | microbial physiological and metabolic engineering, industrial microbiology, synthetic biology, and microbial resource utilization | english.im.cas.cn · im.cas.cn |
| Facility | China General Microbiological Culture Collection (CGMCC) | english.im.cas.cn |
| Facility | CAS-TWAS Center of Excellence for Emerging Infectious Diseases | english.im.cas.cn |
| Grant | National Key R&D Program of China (2021YFC2103500) | pmc.ncbi.nlm.nih.gov |
| Grant | National Natural Science Foundation of China (32270057) | pmc.ncbi.nlm.nih.gov |
| Grant | DNL Cooperation Fund, CAS (DNL202014) | pmc.ncbi.nlm.nih.gov |
| Principal staff | More than 288 researchers, including five CAS academicians | english.im.cas.cn |
| Headcount | More than 490 staff members and nearly 600 graduate students | english.im.cas.cn |
Independent sources: pmc.ncbi.nlm.nih.gov
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| DAC with biointegration (hybrid bio-DAC) | cdr-carbon-management | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.